<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This article describes three rare syndromes in which the presence of α-<z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> provided an important clue to the molecular basis of the underlying condition </plain></SENT>
<SENT sid="1" pm="."><plain>It exemplifies how <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare diseases</z:e> allied with careful clinical observation can lead to important biological principles </plain></SENT>
<SENT sid="2" pm="."><plain>Two of the syndromes, ATR-16 and ATR-X, are characterized by α-<z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> in association with multiple developmental abnormalities including <z:hpo ids='HP_0001249'>mental retardation</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The third condition, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATMDS</z:e>, is an acquired disorder in which α-<z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> arises in the context of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Intriguingly, mutations in the chromatin remodeling factor, ATRX, are common to both ATR-X syndrome and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATMDS</z:e> </plain></SENT>
</text></document>